Terns pharmaceuticals announces initiation of patient dosing in the lift study, a phase 2a clinical trial of tern-101 in development for nash

Terns pharmaceuticals, inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic stea

MDGL Ratings Summary

MDGL Quant Ranking